Navigation Links
Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
Date:7/24/2012

GLENWOOD, Ill., July 24, 2012 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation monitoring, outsourced medical physics services and high quality medical consumable accessories, today announced that it appointed Peter Cempellin to President of Landauer's Radiation Measurement segment effective immediately.

"Pete's previous professional experiences will make him a great addition to Landauer. His involvement with a very dynamic business in positron emission tomography (PET/CT) coupled with his leadership in delivering the first ever commercially viable, FDA approved Time-OF-Flight PET/CT System, is quite impressive.  This was a market changing disruptive technology that changed the imaging landscape," said Bill Saxelby, President and Chief Executive Officer of Landauer, Inc.

In this role, Mr. Cempellin will direct and lead the strategic and operating direction for the Dosimetry Products and Services Business. He will have responsibility for the firm's manufacturing operations, technical laboratory services and international channel partners within the corporation's radiation measurement business segment.

Prior to Landauer, Mr. Cempellin served as President and CEO of CAE Healthcare Inc., a provider of simulation training products including surgical, patient, and ultrasound imaging simulators addressing the educational needs of surgeons, gastroenterologists, cardiologists and intensivists.

Before joining CAE Healthcare, Mr. Cempellin held a variety of executive management positions including Vice President and General Manager at Analogic Corporation, a manufacturer of diagnostic computed tomography (CT) systems and image guided radiation therapy systems (IG-IMRT) and also served as General Manager of Philips Healthcare's Nuclear Medicine Business including PET/CT and molecular imaging systems. Under Mr. Cempellin, Philips Healthcare created the world's first Time-of-Flight PET/CT system, a breakthrough in medical imaging diagnostics and also initiated the world's first whole body PET/MR imaging system.

"Landauer is a world leader in radiation science and services, and I am delighted to join such a dynamic, innovative company," said Mr. Cempellin.  "Given the company's strong position in occupational and patient radiation monitoring and services, I believe there are extraordinary opportunities to grow and build shareholder value. I look forward to working closely with Landauer employees, as well as customers, shareholders and business partners."

Mr. Cempellin earned a Master in Business Administration from Boston University School of Management and a Bachelor of Science in Mechanical Engineering from Northeastern University.

"Pete's marketing capabilities and keen business sense will drive continued product development and market expansion for our Radiation Measurement business segment. His global customer and operations experience will be a key component to Landauer's growth strategy," said Saxelby. "We are excited to welcome Pete to our team."

About Landauer
Landauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services.  For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees.  Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings.  The Company provides its dosimetry services to approximately 1.7 million individuals globally.  In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and imaging physics services to the medical physics community. Through its IZI Medical Products subsidiary, the Company provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures.


'/>"/>
SOURCE Landauer, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
2. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
3. Quanterix Appoints Paul Chapman as President and Chief Executive Officer
4. Conatus Pharmaceuticals Appoints Daniel Ripley As Head Of Corporate Development
5. ShangPharma Independent Committee Appoints Chairman and Legal Counsel
6. C3i Appoints Jonathan Song to Business Development Executive in Asia
7. Organovo Holdings Appoints James T. Glover to Board of Directors
8. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
9. ReShape Medical Appoints Robert E. Grant to Board of Directors
10. Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
11. Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , February 8, 2016 ... report published by Allied Market Research titled, "World ... and Forecasts, 2014-2020", estimates the world synthetic biology ... synthesis and sequencing technology segment would continue to ... software tools segment, collectively, held around half of ...
(Date:2/5/2016)... N.C. , Feb. 5, 2016  Despite the ... been slower than other industries to embrace Big Data ... with utilization. On the medical side, organizations have begun ... everything from clinical trials to adherence. ... from benchmarking firm Best Practices, LLC, Big Data has ...
(Date:2/5/2016)... 5, 2016  Syneron Medical Ltd. (NASDAQ: ... announced today that William Griffing , Chief ... scheduled to participate in the Leerink Partners 5 ... 11, 2016 in New York City ... to meet with the Mr. Griffing and will ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted February ... (ISE®) West Awards. , Awards include the Information Security Executive® of ...
(Date:2/8/2016)... ... 08, 2016 , ... GrassrootsHealth published data from its D*action ... diabetes in the GrassrootsHealth cohort with substantially higher vitamin D levels than a ... health,” states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of ...
(Date:2/8/2016)... ... 08, 2016 , ... The schedule is now online for the ... Conference, which is being held May 25-29 at the Loews Chicago O’Hare Hotel, continues ... and causes of chronic illness in children. , Very recent articles have cited 1 ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
Breaking Medicine News(10 mins):